Tag: UMPIRE clinical trial
Cochlear-backed Aussie innovator raises $16m to test seizure epilepsy monitoring device
Australian medical device innovator Epiminder has raised $16 million to expand its ongoing UMPIRE (sUb-scalp Monitoring ePileptic seIzuREs) clinical trial for Minder®, an ultra-long-term ambulatory electroencephalography...
Featured Article
Driving the future of smart energy: GridBeyond and ABB unveil new white paper on battery storage innovation
As industries adopt cleaner, more intelligent energy solutions, the ability to manage, store, and trade energy efficiently is increasingly vital to sustaining a competitive edge.
